NCT04375293View on ClinicalTrials.gov

Characterisation of the Nasal Microbiome in Patients With N-ERD

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 7, 2020

Primary Completion Date

July 25, 2021

Study Completion Date

July 25, 2021

Conditions
Aspirin Exacerbated Respiratory DiseaseChronic Rhinitis
Interventions
OTHER

Microbiome swabs

Swabs for analysis of microbiome

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT04375293 - Characterisation of the Nasal Microbiome in Patients With N-ERD | Biotech Hunter | Biotech Hunter